Managing Hyperprogressive Disease in the Era of Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Blockade: A Case Discussion and Review of the Literature.

Grecea, Miruna; Marabelle, Aurélien; Ammari, Samy; Massard, Christophe; Champiat, Stéphane

Grecea, Miruna; Marabelle, Aurélien; Ammari, Samy; Massard, Christophe; Champiat, Stéphane.

Afiliación

Grecea M; Drug Development Department (DITEP), Gustave Roussy, Paris-Saclay University, Villejuif, France.
Marabelle A; Drug Development Department (DITEP), Gustave Roussy, Paris-Saclay University, Villejuif, France.
Ammari S; INSERM U1015, Paris-Saclay University, Villejuif, France.
Massard C; Department of Radiology, Gustave Roussy, Paris-Saclay University, Villejuif, France.
Champiat S; Drug Development Department (DITEP), Gustave Roussy, Paris-Saclay University, Villejuif, France.

Oncologist ; 25(5): 369-374, 2020 05.

Article en En | MEDLINE | ID: mdl-32091646

Asunto(s)

Carcinoma de Pulmón de Células no Pequeñas; Neoplasias Pulmonares; Antígeno B7-H1; Humanos; Inmunoterapia; Masculino; Persona de Mediana Edad; Receptor de Muerte Celular Programada 1; Estudios Retrospectivos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male / Middle aged Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Francia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google